Anthropic, OpenAI and Google DeepMind are ramping up efforts to enhance the safety of their advanced AI systems in drug discovery, disease research, and pandemic prevention. These leading labs are implementing biological risk testing, access controls, and biosecurity policies, including synthetic DNA screening. Market pricing currently assigns a 91 % probability to Anthropic having the best AI model by the end of September 2026. This market confidence reflects the growing importance of safety measures as a differentiating factor in the AI sector.
Source: Read the original article
